
<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5HVSFVCN');</script><!--End Google Tag Manager--><title>Intramolecular asymmetric reductive amination: synthesis of enantioenriched dibenz[ c , e ]azepines   - Chemical Science (RSC Publishing) DOI:10.1039/C8SC04482A</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/sc/c8sc04482a"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":9,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Tao Yang"/><meta name="DC.Creator" content="Xiaochong Guo"/><meta name="DC.Creator" content="Qin Yin"/><meta name="DC.Creator" content="Xumu Zhang"/><meta name="DC.title" content="Intramolecular asymmetric reductive amination: synthesis of enantioenriched dibenz[ c , e ]azepines  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2019/02/20"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C8SC04482A"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Intramolecular asymmetric reductive amination: synthesis of enantioenriched dibenz[ c , e ]azepines  "/><meta name="citation_author" content="Tao Yang"/><meta name="citation_author" content="Xiaochong Guo"/><meta name="citation_author" content="Qin Yin"/><meta name="citation_author" content="Xumu Zhang"/><meta name="citation_online_date" content="2018/12/27"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="Chemical Science"/><meta name="citation_volume" content="10"/><meta name="citation_issue" content="8"/><meta name="citation_firstpage" content="2473"/><meta name="citation_lastpage" content="2477"/><meta name="citation_doi" content="10.1039/C8SC04482A"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/sc/c8sc04482a"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/sc/c8sc04482a"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/sc/c8sc04482a"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5HVSFVCN" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/sc/c8sc04482a">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c8sc05474f)" href="/en/content/articlehtml/2019/sc/c8sc05474f" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c8sc04790a)" href="/en/content/articlehtml/2019/sc/c8sc04790a" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C8SC04482A">10.1039/C8SC04482A</a>
(Edge Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2041-6539/2010">Chem. Sci.</a></span>, 2019, <strong>10</strong>, 2473-2477</div><h1 id="sect173"><span class="title_heading">Intramolecular asymmetric reductive amination: synthesis of enantioenriched dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Tao 
            Yang
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Xiaochong 
            Guo
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Qin 
            Yin
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Qin Yin (orcid.org/0000-0003-3534-3786) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-3534-3786"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">ab</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Xumu 
            Zhang
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Xumu Zhang (orcid.org/0000-0001-5700-0608) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-5700-0608"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">a</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Shenzhen Grubbs Institute and Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong 518055, People's Republic of China. E-mail: <a href="mailto:zhangxm@sustc.edu.cn">zhangxm@sustc.edu.cn</a></span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">SUSTech Academy for Advanced Interdisciplinary Studies, Southern University of Science and Technology, Shenzhen, Guangdong 518055, People's Republic of China. E-mail: <a href="mailto:yinq@sustc.edu.cn">yinq@sustc.edu.cn</a></span>
    </p><div id="art-admin"><span class="italic bold">Received 
      9th October 2018
    </span><span class="bold italic">, Accepted 21st December 2018</span></div><p class="bold italic">First published on 27th December 2018</p><hr/><div class="abstract"><h2>Abstract</h2><p>An Ir-catalyzed intramolecular asymmetric reductive amination (ARA) of bridged biaryl derivatives has been described. Using this unprecedented approach, synthetically useful dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines containing both central and axial chiralities are obtained with excellent enantiocontrol (up to 97% ee). This methodology represents a rare example of enantioselective chemocatalytic synthesis of chiral dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines featuring a broad substrate scope, and their synthetic utilities are exhibited by derivatizing the products into a chiral amino acid derivative and chiral phosphoramidite ligands, which display excellent enantiocontrol in Rh-catalyzed asymmetric hydrogenation of α-dehydroamino acid derivatives. Remarkably, our method is also applicable to enantioselectively synthesize an allocolchicine analogue.</p></div><hr/>
    
      <h2 id="sect232"><span class="a_heading">Introduction</span></h2>
      <span>Dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines are a class of unique 7-membered cyclic amines featuring a biaryl bridge and have attracted increasing attention due to their importance in biological and synthetic chemistry.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> For instance, compound <strong>A</strong> is the active ingredient in an anti-obesity drug,<a title="Select to navigate to references" href="#cit2"><sup><span class="sup_ref">2</span></sup></a> and <strong>B</strong> is considered to be an allocolchicine analogue.<a title="Select to navigate to references" href="#cit3"><sup><span class="sup_ref">3</span></sup></a> In addition, dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepine-based compounds <strong>C</strong>, <strong>D</strong>, and <strong>E</strong> and compound <strong>F</strong> have found promising applications in either organocatalysis or asymmetric transition metal catalysis (eqn (a), <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>). Of particular interest is the phenomenon that a central to axial chirality relay occurs when a stereogenic substituent is placed at the α-position of the nitrogen atom of <strong>2a</strong>. Moreover, enantiomerically pure dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines can function as a molecular switch with the axial chirality inverting upon N-Boc derivatisation caused by the center-axis relay effect (eqn (b), <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to reference" href="#cit4"><sup><span class="sup_ref">4a</span></sup></a></span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-f1.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">(a) Selected examples containing a dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepine structural unit; (b) central to axial chirality relay phenomenon; (c) our proposed one pot N-Boc deprotection/intramolecular ARA sequence for the synthesis of enantioenriched dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Despite their biological properties and promising applications in organic synthesis, asymmetric synthesis of this kind of framework lags behind and only a few examples were reported. In 2000, Kündig and coworkers developed a pioneering synthetic strategy towards chiral base <strong>C</strong>, featuring a Pd-catalyzed atropo-diastereoselective coupling to construct the Ar–Ar bond in a later stage with chiral-pool starting materials.<a title="Select to navigate to reference" href="#cit5"><sup><span class="sup_ref">5a</span></sup></a> Later, by making use of an auxiliary strategy,<a title="Select to navigate to references" href="#cit4"><sup><span class="sup_ref">4</span></sup></a> Wallace <span class="italic">et al.</span> prepared a conformationally labile secondary amine <strong>2a</strong> involving a center-axis stereochemical relay.<a title="Select to navigate to references" href="#cit4a"><sup><span class="sup_ref">4a</span></sup></a> Very recently, Turner and coworkers described an elegant biocatalytic route to access enantiomerically pure dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines by utilizing imine reductase (IRED) biocatalysts.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> To our knowledge, highly efficient chemical catalytic systems capable of directly providing structurally diverse chiral dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines have never been reported.<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a> The lack of efficient methods toward enantioenriched dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines has greatly impeded deeper studies on the structure–function relationship and synthetic applications of these unique chiral cyclic amines.</p>
      <p class="otherpara">Transition metal-catalyzed asymmetric reductive amination represents a straightforward and step-economical method for the synthesis of chiral amines from readily available ketones.<a title="Select to navigate to references" href="#cit8"><sup><span class="sup_ref">8</span></sup></a> However, this field remains underdeveloped compared to the well-studied imine asymmetric hydrogenation.<a title="Select to navigate to references" href="#cit9"><sup><span class="sup_ref">9</span></sup></a></p>
      <p class="otherpara">Recently, intramolecular ARA has exhibited great potential in the construction of chiral 5- and 6-membered N-heterocycles.<a title="Select to navigate to references" href="#cit10"><sup><span class="sup_ref">10</span></sup></a> In contrast, related applications for the synthesis of 7-membered N-heterocycles remain underdeveloped. To continue our interest in ARA with molecular H<small><sub>2</sub></small>,<a title="Select to navigate to references" href="#cit8k"><sup><span class="sup_ref">8k</span></sup></a> we wondered if this strategy was also applicable to synthesize chiral 7-membered dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines efficiently. Herein, we report the first enantioselective synthesis of dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines through a one pot N-Boc deprotection/intramolecular ARA sequence (eqn (c), <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>). The synthetic utilities of the enantioenriched products are also presented.</p>
    
    
      <h2 id="sect291"><span class="a_heading">Results and discussion</span></h2>
      <span>Inspired by Turner's elegant work<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> and our recent discovery on ARA,<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> aryl-bridged aminoketone <strong>1a</strong> was prepared and selected as the model substrate for our research. We envisaged that <strong>1a</strong> could undergo N-Boc deprotection promoted by HCl/Et<small><sub>2</sub></small>O and subsequent ARA enabled by the Ir/ZhaoPhos complex to provide enantioenriched product <strong>2a</strong>. After the removal of all volatile components from the first step, the resulting mixture was treated with 30 atm of H<small><sub>2</sub></small> for the ARA step in the presence of a catalyst combination of [Ir(COD)Cl]<small><sub>2</sub></small> and ZhaoPhos using DCM as a solvent and Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> as an additive. Delightfully, the reaction gave the desired product <strong>2a</strong> in moderate conversion (65%) albeit with promising enantioselectivity (36% ee), together with the formation of imine intermediate <strong>2a′</strong> (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 1). Unexpectedly, without Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small>, the reduction process did not work, suggesting the key role of Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> in accelerating the reduction process.<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> Screening of other solvents, such as EtOAc, THF, <small><sup>i</sup></small>PrOH, MeOH, toluene and MeCN, disclosed that <small><sup>i</sup></small>PrOH was the best choice, providing the desired <strong>2a</strong> in 77% ee.<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> Despite moderate enantiocontrol in the Ir/ZhaoPhos catalytic system, these positive results confirmed our hypothesis and encouraged us to further modify the catalyst combination with the expectation of improving the ee to an excellent level.</span>
      
<div class="table_caption"><b>Table 1</b> <span id="tab1">Evaluation of additives and solvents for Ir/ZhaoPhos-catalyzed ARA of <strong>1a</strong><i><small><sup style="color: red;"><a title="" href="#tab1fna">a</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/></colgroup>
            
            
            
            
            
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th colspan="6" align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u1.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u1.gif"/></a></p>
                </th>
              </tr>
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">Entry</th>
                <th align="left" valign="bottom" class="border_black">Additive</th>
                <th align="left" valign="bottom" class="border_black">Solvent</th>
                <th align="left" valign="bottom" class="border_black">Conv.<i><small><sup style="color: red;"><a title="" href="#tab1fnb">b</a></sup></small></i> (%)</th>
                <th align="left" valign="bottom" class="border_black">
                  <strong>2a</strong>/<strong>2a′</strong><i><small><sup style="color: red;"><a title="" href="#tab1fnb">b</a></sup></small></i></th>
                <th align="left" valign="bottom" class="border_black">
                  <strong>2a</strong>: ee<i><small><sup style="color: red;"><a title="" href="#tab1fnc">c</a></sup></small></i> (%)</th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th colspan="6">
                  <a id="tab1fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1a</strong> (0.1 mmol), [Ir(COD)Cl]<small><sub>2</sub></small> (0.5 mol%), ZhaoPhos (1.1 mol%), HCl/Et<small><sub>2</sub></small>O (4.0 equiv.), Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> (1 equiv.), and solvent (0.6 mL).</span>
                  <a id="tab1fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">Determined by <small><sup>1</sup></small>H NMR.</span>
                  <a id="tab1fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">Determined by HPLC for the corresponding benzamides.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">1</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">DCM</td>
                <td valign="top">&gt;99</td>
                <td valign="top">65/35</td>
                <td valign="top">36 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">2</td>
                <td valign="top">—</td>
                <td valign="top">DCM</td>
                <td valign="top">&gt;99</td>
                <td valign="top">0/100</td>
                <td valign="top">—</td>
              </tr>
              <tr align="left">
                <td valign="top">3</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">EtOAc</td>
                <td valign="top">&gt;99</td>
                <td valign="top">60/40</td>
                <td valign="top">55 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">4</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">
                  <small><sup>i</sup></small>PrOH</td>
                <td valign="top">&gt;99</td>
                <td valign="top">86/14</td>
                <td valign="top">77 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">5</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">THF</td>
                <td valign="top">&gt;99</td>
                <td valign="top">79/21</td>
                <td valign="top">66 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">6</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">MeOH</td>
                <td valign="top">&gt;99</td>
                <td valign="top">75/25</td>
                <td valign="top">72 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">7</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">Toluene</td>
                <td valign="top">&gt;99</td>
                <td valign="top">72/28</td>
                <td valign="top">12 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">8</td>
                <td valign="top">Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small></td>
                <td valign="top">MeCN</td>
                <td valign="top">&gt;99</td>
                <td valign="top">42/58</td>
                <td valign="top">50 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">We subsequently evaluated a diverse array of commercially available chiral diphosphine ligands (<a title="Select to navigate to table" href="#tab2">Table 2</a>). The most popular diphosphine ligand BINAP was first tried, giving the product <strong>2a</strong> in high conversion (90%) but low enantioselectivity (40% ee) (<a title="Select to navigate to table" href="#tab2">Table 2</a>, entry 2). Satisfactorily, double oxygenated diphosphine ligands including SegPhos, MeO–BiPhep and DifluorPhos displayed higher enantiocontrol (<a title="Select to navigate to table" href="#tab2">Table 2</a>, entries 3–8). Particularly, DifluorPhos delivered the highest enantioselectivity (94% ee; <a title="Select to navigate to table" href="#tab2">Table 2</a>, entry 8). Lowering the reaction temperature to 20 °C led to a slight improvement of the enantiocontrol (96% ee, 89% yield; <a title="Select to navigate to table" href="#tab2">Table 2</a>, entry 9). The pressure of H<small><sub>2</sub></small> was also evaluated, and the conversion slightly dropped to 90% with 20 atm of H<small><sub>2</sub></small>, without affecting the enantioselectivity (<a title="Select to navigate to table" href="#tab2">Table 2</a>, entry 10).</p>
      
<div class="table_caption"><b>Table 2</b> <span id="tab2">Further condition optimization of the ARA of <strong>1a</strong><i><small><sup style="color: red;"><a title="" href="#tab2fna">a</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/></colgroup>
            
            
            
            
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th colspan="5" align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u2.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u2.gif"/></a></p>
                </th>
              </tr>
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">Entry</th>
                <th align="left" valign="bottom" class="border_black">Ligand</th>
                <th align="left" valign="bottom" class="border_black">Conv.<i><small><sup style="color: red;"><a title="" href="#tab2fnb">b</a></sup></small></i> (%)</th>
                <th align="left" valign="bottom" class="border_black">
                  <strong>2a</strong>/<strong>2a′</strong><i><small><sup style="color: red;"><a title="" href="#tab2fnb">b</a></sup></small></i></th>
                <th align="left" valign="bottom" class="border_black">
                  <strong>2a</strong>: ee<i><small><sup style="color: red;"><a title="" href="#tab2fnc">c</a></sup></small></i> (%)</th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th colspan="5">
                  <a id="tab2fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1a</strong> (0.1 mmol), [Ir(COD)Cl]<small><sub>2</sub></small> (0.5 mol%), ligand (1.1 mol%), HCl/Et<small><sub>2</sub></small>O (4.0 equiv.), Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> (1 equiv.) and solvent (0.6 mL).</span>
                  <a id="tab2fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">Determined by <small><sup>1</sup></small>H NMR; isolated yield of <strong>2a</strong> in parentheses.</span>
                  <a id="tab2fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">Determined by HPLC for the corresponding benzamides.</span>
                  <a id="tab2fnd"><span class="tfootnote">d</span></a> <span class="sup_inf">The reaction was conducted at 20 °C.</span>
                  <a id="tab2fne"><span class="tfootnote">e</span></a> <span class="sup_inf">20 atm of H<small><sub>2</sub></small> was used.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">1</td>
                <td valign="top">ZhaoPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">86/14</td>
                <td valign="top">77 (<span class="italic">R</span>, a<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">2</td>
                <td valign="top">(<span class="italic">S</span>)-BINAP</td>
                <td valign="top">&gt;99</td>
                <td valign="top">90/10</td>
                <td valign="top">40 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">3</td>
                <td valign="top">(<span class="italic">S</span>)-SegPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">92 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">4</td>
                <td valign="top">(<span class="italic">S</span>)-DM-SegPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">80 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">5</td>
                <td valign="top">(<span class="italic">S</span>)-DTBM-SegPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">40 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">6</td>
                <td valign="top">(<span class="italic">S</span>)-MeO-BiPhep</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">86 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">7</td>
                <td valign="top">(<span class="italic">S</span>)-MeO-DM-BiPhep</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">53 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">8</td>
                <td valign="top">(<span class="italic">S</span>)-DifluorPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;99/1</td>
                <td valign="top">94 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">
                  <span class="bold">9</span>
                  <i><small><sup style="color: red;"><a title="" href="#tab2fnd">
                  </a></sup></small></i>
                </td>
                <td valign="top">
                  <span class="bold">(<span class="italic">S</span>)-DifluorPhos</span>
                </td>
                <td valign="top">
                  <span class="bold">&gt;99</span>
                </td>
                <td valign="top">
                  <span class="bold">&gt;99/1 (89)</span>
                </td>
                <td valign="top">
                  <span class="bold">96 (<span class="italic">S</span>, a<span class="italic">R</span>)</span>
                </td>
              </tr>
              <tr align="left">
                <td valign="top">10<i><small><sup style="color: red;"><a title="" href="#tab2fne">e</a></sup></small></i></td>
                <td valign="top">(<span class="italic">S</span>)-DifluorPhos</td>
                <td valign="top">&gt;99</td>
                <td valign="top">&gt;90/10</td>
                <td valign="top">96 (<span class="italic">S</span>, a<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td colspan="5" valign="top">
                  <a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u3.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u3.gif"/></a>
                </td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">Under the optimal reaction conditions, the substrate scope was then studied, as depicted in <a title="Select to navigate to table" href="#tab3">Table 3</a>. We first examined methyl ketones with various substituents (Me, MeO, F, Cl, CF<small><sub>3</sub></small>, <span class="italic">etc.</span>) on both of the bridged benzene rings. In general, all tested substrates provided the corresponding enantioenriched dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines in high yields and excellent ees (<strong>2b–2k</strong>, 87–94% yields, 89–97% ee), regardless of the nature and position of the substituents. Remarkably, pyridine-bridged substrate <strong>1l</strong> is also applicable, yielding the corresponding product <strong>2l</strong> in 89% yield and 84% ee. It is noteworthy that 2 equivalents of Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> are required to enable good conversion, which is possibly due to the competitive coordination of the N atom on the pyridine <span class="italic">versus</span> the N atom of imine. Disappointingly, the enantiocontrol is very susceptible to the steric bulk of the substituent <span class="italic">R</span><small><sup>3</sup></small>. Ethyl-substituted substrates (<strong>1m</strong>) afforded the product with dramatically decreased enantioselectivity (60% ee for <strong>2m</strong>).</p>
      
<div class="table_caption"><b>Table 3</b> <span id="tab3">Substrate scope for alkylketones<i><small><sup style="color: red;"><a title="" href="#tab3fna">a</a></sup></small></i><small><sup>,</sup></small><i><small><sup style="color: red;"><a title="" href="#tab3fnb">b</a></sup></small></i><small><sup>,</sup></small><i><small><sup style="color: red;"><a title="" href="#tab3fnc">c</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/></colgroup>
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u4.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u4.gif"/></a></p>
                </th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th>
                  <a id="tab3fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1</strong> (0.1 mmol), [Ir(COD)Cl]<small><sub>2</sub></small> (0.5 mol%), (<span class="italic">S</span>)-DifluorPhos (1.1 mol%), HCl/Et<small><sub>2</sub></small>O (4.0 equiv.), Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> (1.0 equiv.), and <small><sup>i</sup></small>PrOH (0.6 mL).</span>
                  <a id="tab3fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">Isolated yields.</span>
                  <a id="tab3fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">Determined by HPLC on a chiral stationary phase for the corresponding benzamides.</span>
                  <a id="tab3fnd"><span class="tfootnote">d</span></a> <span class="sup_inf">2.0 equiv. of Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> was used.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">
                  <a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u5.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u5.gif"/></a>
                </td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">When we applied the above-mentioned standard reaction conditions to diarylketone-derived substrates, inferior performance was unfortunately observed in terms of both reactivity and enantiocontrol. After re-optimizing the reaction conditions with <strong>1n</strong>, including the evaluation of the ligands, H<small><sub>2</sub></small> pressure and the reaction time (see the ESI<a title="Select to navigate to footnote" href="#fn1">†</a> for details), we were glad to discover that the desired reductive amination product <strong>2n</strong> could be obtained in 72% yield and 89% ee in the presence of the [Ir(COD)Cl]<small><sub>2</sub></small>/(<span class="italic">S</span>)-SegPhos complex and 60 atm of H<small><sub>2</sub></small> for 48 h. The moderate yield of <strong>2n</strong> was caused by the low reactivity of the imine intermediate towards reduction.</p>
      <p class="otherpara">With the slightly revised reaction conditions, we found that several substrates (<strong>1o</strong> to <strong>1s</strong>) contain either a Me, F, MeO or Cl substituent on each benzene ring, as summarized in <a title="Select to navigate to table" href="#tab4">Table 4</a>. Gratifyingly, all examined substrates underwent the reaction smoothly to yield the corresponding products in decent to good yields with generally good ee (<strong>2o–2s</strong>, up to 81% yield and 91% ee).</p>
      
<div class="table_caption"><b>Table 4</b> <span id="tab4">Substrate scope for diarylketones<i><small><sup style="color: red;"><a title="" href="#tab4fna">a</a></sup></small></i><small><sup>,</sup></small><i><small><sup style="color: red;"><a title="" href="#tab4fnb">b</a></sup></small></i><small><sup>,</sup></small><i><small><sup style="color: red;"><a title="" href="#tab4fnc">c</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/></colgroup>
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u6.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u6.gif"/></a></p>
                </th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th>
                  <a id="tab4fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1</strong> (0.1 mmol), [Ir(COD)Cl]<small><sub>2</sub></small> (2 mol%), (<span class="italic">S</span>)-SegPhos (4.4 mol%), HCl/Et<small><sub>2</sub></small>O (4.0 equiv.), Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> (1.0 equiv.), and <small><sup>i</sup></small>PrOH (0.6 mL).</span>
                  <a id="tab4fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">Isolated yields.</span>
                  <a id="tab4fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">Determined by UPLC on a chiral stationary phase.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">
                  <a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-u7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-u7.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-u7.gif"/></a>
                </td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">To demonstrate the practical utility of this method, scale-up synthesis of <strong>2a</strong> was performed on the 1.5 mmol scale, producing <strong>2a</strong> in 88% yield and 96% ee. Dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepine <strong>B</strong> is an analogue of the alkaloid allocolchicine with bioactivity against antimicrotubules and was originally synthesized by Baudoin and co-workers<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a> from chiral-pool starting materials. We were curious if our catalytic asymmetric method could be applied to achieve the biologically active molecule <strong>B</strong>. To test our idea, imine hydrochloride salt <strong>3</strong> was prepared because direct ARA was unsuccessful. When <strong>3</strong> HCl was subjected to the standard hydrogenation conditions (DifluorPhos as the ligand), the desired product <strong>B</strong> was unfortunately obtained with poor enantiocontrol (25% ee). Nevertheless, 81% yield and 75% ee of <strong>B</strong> were achieved when ZhaoPhos was used as the ligand (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-s1.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Scale-up synthesis of <strong>2a</strong> and asymmetric hydrogenation towards bioactive compound <strong>B</strong>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">The obtained enantioenriched axially chiral biaryl amines could be easily derivatized into the Kündig amine <strong>4</strong> with a procedure reported by Wallace.<a title="Select to navigate to references" href="#cit4a"><sup><span class="sup_ref">4a</span></sup></a> Likely, treatment of the N-Boc derivative <strong>5</strong>, prepared from <strong>2a</strong>, with <strong>5</strong> equivalents of Schlosser's “LIDAKOR” base<a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a> at −78 °C, followed by a quenching operation with methyl chloroformate, provided <strong>6</strong> as a mixture of two rotamers.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> Subsequent removal of the Boc group using HCl/Et<small><sub>2</sub></small>O afforded enantioenriched seven-membered cyclic amino acid derivative <strong>7</strong> in a high yield (top, <a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><a href="/image/article/2019/SC/c8sc04482a/c8sc04482a-s2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8sc04482a-s2.tif" src="/image/article/2019/SC/c8sc04482a/c8sc04482a-s2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Synthetic applications of <strong>2a</strong>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">In addition, two chiral monodentate phosphorus ligands <strong>L1</strong> and <strong>L2</strong> were efficiently synthesized by condensation of the chiral amine <strong>2a</strong> with (<span class="italic">R</span>) or (<span class="italic">S</span>)-(1,1′-binaphthyl-2,2′-diyl) chlorophosphite. The application of both ligands in rhodium-catalyzed asymmetric hydrogenation of α-dehydroamino acid derivatives<a title="Select to navigate to references" href="#cit17"><sup><span class="sup_ref">17</span></sup></a> afforded the hydrogenated product with excellent enantioselectivity (bottom, <a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>).</p>
    
    
      <h2 id="sect732"><span class="a_heading">Conclusions</span></h2>
      <span>In summary, we have developed a highly enantioselective method towards chiral dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines through a one pot N-Boc deprotection/intramolecular ARA sequence of bridged biaryl derivatives. Under optimal reaction conditions, dibenz[<span class="italic">c</span>,<span class="italic">e</span>]azepines containing both central and axial chiralities are conveniently obtained with generally excellent enantiocontrol (up to 97% ee). Our method represents an intriguing catalytic enantioselective synthesis of Ar-bridged axially cyclic amines. The synthetic utility of the developed method was exhibited by an unprecedented enantioselective synthesis of an analogue of allocolchicine. Derivatisation of the obtained product into more complicated and synthetically interesting amino acid derivatives and chiral ligands for transition metal catalysis was also performed.</span>
    
    
      <h2 id="sect739"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts to declare.</span>
    
  
    <h2 id="sect743"><span class="a_heading">Acknowledgements</span></h2>
      <span>We are grateful to the Southern University of Science and Technology, the Shenzhen Science and Technology Innovation Committee (No. KQTD20150717103157174, JSGG20160608140847864 and JCYJ20170817110055425), the Shenzhen Nobel Prize Scientists Laboratory Project (C17783101) and the National Natural Science Foundation of China (No. 21432007 and 21801119) for financial support.</span>
    
    <span id="sect745"><h2 id="sect742"><span class="a_heading">Notes and references</span></h2></span><ol type="1">
      <li><span id="cit1">
  (<i>&#97;</i>) <span id="cit1a">X. Gu, Z. Ren, X. Tang, H. Peng, Q. Zhao, Y. Lai, S. Peng and Y. Zhang, <span class="italic">Eur. J. Med. Chem.</span>, 2012, <span class="bold">51</span>, 137 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2012.02.034" title="DOI Link to resource 10.1016/j.ejmech.2012.02.034">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XmtlSls7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22405646%5Buid%5D" title="PubMed Link to resource 22405646">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit1b">S. A. Bright, A. BrinkØ, M. T. Larsen, S. Sinning, D. C. Williams and H. H. Jensen, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 2013, <span class="bold">23</span>, 1220 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bmcl.2013.01.020" title="DOI Link to resource 10.1016/j.bmcl.2013.01.020">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKmtbg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23385211%5Buid%5D" title="PubMed Link to resource 23385211">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit1c">S. Pache, C. Botuha, R. Franz, E. P. Kündig and J. Einhorn, <span class="italic">Helv. Chim. Acta</span>, 2000, <span class="bold">83</span>, 2436 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/1522-2675(20000906)83:9&lt;2436::AID-HLCA2436&gt;3.0.CO;2-N" title="DOI Link to resource 10.1002/1522-2675(20000906)83:9&lt;2436::AID-HLCA2436&gt;3.0.CO;2-N">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXnsVymsrs%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#100;</i>) <span id="cit1d">T. Kano, H. Sugimoto and K. Maruoka, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>, 18130 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja208873k" title="DOI Link to resource 10.1021/ja208873k">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrs7fK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21999103%5Buid%5D" title="PubMed Link to resource 21999103">PubMed</a></span>; 
  (<i>&#101;</i>) <span id="cit1e">T. Kano, S. Song, Y. Kubota and K. Maruoka, <span class="italic">Angew. Chem., Int. Ed.</span>, 2012, <span class="bold">51</span>, 1191 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201107375" title="DOI Link to resource 10.1002/anie.201107375">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhs1elu7zP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22173941%5Buid%5D" title="PubMed Link to resource 22173941">PubMed</a></span>; 
  (<i>&#102;</i>) <span id="cit1f">P. C. B. Page, J. C. Bartlett, Y. Chan, D. Day, P. Parker, B. R. Buckley, G. A. Rassias, A. M. Z. Slawin, S. M. Allin, J. Lacour and A. Pinto, <span class="italic">J. Org. Chem.</span>, 2012, <span class="bold">77</span>, 6128 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo300915u" title="DOI Link to resource 10.1021/jo300915u">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22708806%5Buid%5D" title="PubMed Link to resource 22708806">PubMed</a></span>; 
  (<i>&#103;</i>) <span id="cit1g">M. Gerdin, M. Penhoat, C. Pétermann and C. Moberg, <span class="italic">J. Organomet. Chem.</span>, 2008, <span class="bold">693</span>, 3519 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jorganchem.2008.08.029" title="DOI Link to resource 10.1016/j.jorganchem.2008.08.029">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLrE" title="Link to resource in CAS">CAS</a></span>.</span></li>
      <li><span id="cit2">
          M. De Lera Ruiz, Y. M. Berlin, J. Zheng, R. G. Aslanian, K. D. McCormick and Q. Zeng, WO2010011653 A1,  2010.</span></li>
      <li><span id="cit3">I. H. Hall, A. R. K. Murthy and S. D. Wyrick, <span class="italic">J. Pharm. Sci.</span>, 1986, <span class="bold">75</span>, 622 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/jps.2600750622" title="DOI Link to resource 10.1002/jps.2600750622">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL28XlsVGltb8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=3735111%5Buid%5D" title="PubMed Link to resource 3735111">PubMed</a>.</span></li>
      <li><span id="cit4">
  (<i>&#97;</i>) <span id="cit4a">S. L. Pira, T. W. Wallace and J. P. Graham, <span class="italic">Org. Lett.</span>, 2009, <span class="bold">11</span>, 1663 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol900333c" title="DOI Link to resource 10.1021/ol900333c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXjtFKnsL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19275220%5Buid%5D" title="PubMed Link to resource 19275220">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit4b">S. Postikova, M. Sabbah, D. Wightman, I. T. Nguyen, M. Sanselme, T. Besson, J. F. Brière, S. Oudeyer and V. Levacher, <span class="italic">J. Org. Chem.</span>, 2013, <span class="bold">78</span>, 8191 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo401259w" title="DOI Link to resource 10.1021/jo401259w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23919590%5Buid%5D" title="PubMed Link to resource 23919590">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit4c">P. C. Bulman Page, C. A. Pearce, Y. Chan, P. Parker, B. R. Buckley, G. A. Rassias and M. R. J. Elsegood, <span class="italic">J. Org. Chem.</span>, 2015, <span class="bold">80</span>, 8036 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.5b01157" title="DOI Link to resource 10.1021/acs.joc.5b01157">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXht1altLjK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26204427%5Buid%5D" title="PubMed Link to resource 26204427">PubMed</a></span>.</span></li>
      <li><span id="cit5">
  (<i>&#97;</i>) <span id="cit5a">L. A. Saudan, G. Bernardinelli and E. P. Kündig, <span class="italic">Synlett</span>, 2000, 483 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXivVahs7o%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit5b">C. A. Cheetham, R. S. Massey, S. L. Pira, R. G. Pritchard and T. W. Wallace, <span class="italic">Org. Biomol. Chem.</span>, 2011, <span class="bold">9</span>, 1831 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C0OB00889C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C0OB00889C">RSC</a></span>.</span></li>
      <li><span id="cit6">S. P. France, G. A. Aleku, M. Sharma, J. Mangas-Sanchez, R. M. Howard, J. Steflik, R. Kumar, R. W. Adams, I. Slabu, R. Crook, G. Grogan, T. W. Wallace and N. J. Turner, <span class="italic">Angew. Chem., Int. Ed.</span>, 2017, <span class="bold">56</span>, 15589 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201708453" title="DOI Link to resource 10.1002/anie.201708453">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhslyhtL%252FM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29024400%5Buid%5D" title="PubMed Link to resource 29024400">PubMed</a>.</span></li>
      <li><span id="cit7">For recent work on the synthesis of chiral dibenzo[<span class="italic">b</span>,<span class="italic">d</span>]azepines, see   J. Liu, X. Yang, Z. Zuo, J. Nan, Y. Wang and X. Luan, <span class="italic">Org. Lett.</span>, 2018, <span class="bold">20</span>, 244 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.7b03605" title="DOI Link to resource 10.1021/acs.orglett.7b03605">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCqt7fJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29231741%5Buid%5D" title="PubMed Link to resource 29231741">PubMed</a>.</span></li>
      <li><span id="cit8">For reviews and selected examples of TM-catalyzed ARA, see 
  (<i>&#97;</i>) <span id="cit8a">T. C. Nugent and M. El-Shazly, <span class="italic">Adv. Synth. Catal.</span>, 2010, <span class="bold">352</span>, 753 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.200900719" title="DOI Link to resource 10.1002/adsc.200900719">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjvF2msbY%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit8b">C. Wang and J. Xiao, <span class="italic">Top. Curr. Chem.</span>, 2014, <span class="bold">343</span>, 261 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/128_2013_484" title="DOI Link to resource 10.1007/128_2013_484">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXovFens7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24158548%5Buid%5D" title="PubMed Link to resource 24158548">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit8c">H.-U. Blaser, H.-P. Buser, H.-P. Jalett, B. Pugin and F. Spindler, <span class="italic">Synlett</span>, 1999, 867 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-1999-3106" title="DOI Link to resource 10.1055/s-1999-3106">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXjvFGjsr0%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#100;</i>) <span id="cit8d">R. Kadyrov and T. H. Riermeier, <span class="italic">Angew. Chem., Int. Ed.</span>, 2003, <span class="bold">42</span>, 5472 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200352503" title="DOI Link to resource 10.1002/anie.200352503">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXpsFyjsbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14618579%5Buid%5D" title="PubMed Link to resource 14618579">PubMed</a></span>; 
  (<i>&#101;</i>) <span id="cit8e">R. Kadyrov, T. H. Riermeier, U. Dingerdissen, V. Tararov and A. Börner, <span class="italic">J. Org. Chem.</span>, 2003, <span class="bold">68</span>, 4067 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo020690k" title="DOI Link to resource 10.1021/jo020690k">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXjtVOrt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12737592%5Buid%5D" title="PubMed Link to resource 12737592">PubMed</a></span>; 
  (<i>&#102;</i>) <span id="cit8f">L. Rubio-Pérez, F. J. PérezFlores, P. Sharma, L. Velasco and A. Cabrera, <span class="italic">Org. Lett.</span>, 2009, <span class="bold">11</span>, 265 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol802336m" title="DOI Link to resource 10.1021/ol802336m">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19093803%5Buid%5D" title="PubMed Link to resource 19093803">PubMed</a></span>; 
  (<i>&#103;</i>) <span id="cit8g">C. Li, B. Villa-Marcos and J. Xiao, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>, 6967 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja9021683" title="DOI Link to resource 10.1021/ja9021683">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXltFOlu74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19402701%5Buid%5D" title="PubMed Link to resource 19402701">PubMed</a></span>; 
  (<i>&#104;</i>) <span id="cit8h">S. Zhu, S. Fleischer, H. Jiao, K. Junge and M. Beller, <span class="italic">Adv. Synth. Catal.</span>, 2014, <span class="bold">356</span>, 3451 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.201400328" title="DOI Link to resource 10.1002/adsc.201400328">CrossRef</a></span>; 
  (<i>&#105;</i>) <span id="cit8i">H. Huang, X. Liu, L. Zhou, M. Chang and X. Zhang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 5309 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201601025" title="DOI Link to resource 10.1002/anie.201601025">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XktlKmuro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26992130%5Buid%5D" title="PubMed Link to resource 26992130">PubMed</a></span>; 
  (<i>&#106;</i>) <span id="cit8j">D. Steinhuebel, Y. Sun, K. Matsumura, N. Sayo and T. Saito, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>, 11316 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja905143m" title="DOI Link to resource 10.1021/ja905143m">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXptFChtr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19637921%5Buid%5D" title="PubMed Link to resource 19637921">PubMed</a></span>; 
  (<i>&#107;</i>) <span id="cit8k">X. Tan, S. Gao, W. Zeng, S. Xin, Q. Yin and X. Zhang, <span class="italic">J. Am. Chem. Soc.</span>, 2018, <span class="bold">140</span>, 2024 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b12898" title="DOI Link to resource 10.1021/jacs.7b12898">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhsl2jtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29377687%5Buid%5D" title="PubMed Link to resource 29377687">PubMed</a></span>; 
  (<i>&#108;</i>) <span id="cit8l">J. Gallardo-Donaire, M. Hermsen, J. Wysocki, M. Ernst, F. Rominger, O. Trapp, A. S. K. Hashmi, A. Schäfer, P. Comba and T. Schaub, <span class="italic">J. Am. Chem. Soc.</span>, 2018, <span class="bold">140</span>, 355 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b10496" title="DOI Link to resource 10.1021/jacs.7b10496">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsLnM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29195041%5Buid%5D" title="PubMed Link to resource 29195041">PubMed</a></span>; 
  (<i>&#109;</i>) <span id="cit8m">P. Yang, L. H. Lim, P. Chuanprasit, H. Hirao and J. Zhou, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 12083 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201606821" title="DOI Link to resource 10.1002/anie.201606821">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsVChtLnI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27572720%5Buid%5D" title="PubMed Link to resource 27572720">PubMed</a></span>.</span></li>
      <li><span id="cit9">For selected recent reviews on TM-catalyzed asymmetric imine hydrogenation, see 
  (<i>&#97;</i>) <span id="cit9a">J. Xie, S. Zhu and Q. Zhou, <span class="italic">Chem. Rev.</span>, 2011, <span class="bold">111</span>, 1713 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr100218m" title="DOI Link to resource 10.1021/cr100218m">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOqtrvP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21166392%5Buid%5D" title="PubMed Link to resource 21166392">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit9b">W. Tang and J. Xiao, <span class="italic">Synthesis</span>, 2014, <span class="bold">46</span>, 1297 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-0033-1338603" title="DOI Link to resource 10.1055/s-0033-1338603">CrossRef</a></span>; 
  (<i>&#99;</i>) <span id="cit9c">D. Wang, C. Hou, L. Chen, X. Liu, Q. An and X. Hu, <span class="italic">Chin. J. Org. Chem.</span>, 2013, <span class="bold">33</span>, 1355 <a target="_blank" class="DOILink" href="https://doi.org/10.6023/cjoc201211036" title="DOI Link to resource 10.6023/cjoc201211036">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhvFalsLrI" title="Link to resource in CAS">CAS</a></span>.</span></li>
      <li><span id="cit10">For TM-catalyzed intramolecular ARA, see 
  (<i>&#97;</i>) <span id="cit10a">F. Chen, Z. Ding, J. Qin, T. Wang, Y. He and Q. Fan, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 4348 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol201679f" title="DOI Link to resource 10.1021/ol201679f">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXptVSrt7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21766831%5Buid%5D" title="PubMed Link to resource 21766831">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit10b">Y. Zhang, Q. Yan, G. Zi and G. Hou, <span class="italic">Org. Lett.</span>, 2017, <span class="bold">19</span>, 4215 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.7b01828" title="DOI Link to resource 10.1021/acs.orglett.7b01828">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXht1Cls7bI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28762747%5Buid%5D" title="PubMed Link to resource 28762747">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit10c">B. Song, C. Yu, Y. Ji, M. Chen and Y. Zhou, <span class="italic">Chem. Commun.</span>, 2017, <span class="bold">53</span>, 1704 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6CC09493G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6CC09493G">RSC</a></span>; 
  (<i>&#100;</i>) <span id="cit10d">N. A. Strotman, C. A. Baxter, K. M. J. Brands, E. Cleator, S. W. Krska, R. A. Reamer, D. J. Wallace and T. J. Wright, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>, 8362 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja202358f" title="DOI Link to resource 10.1021/ja202358f">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21528938%5Buid%5D" title="PubMed Link to resource 21528938">PubMed</a></span>; 
  (<i>&#101;</i>) <span id="cit10e">G. D. Williams, R. A. Pike, C. E. Wade and M. Wills, <span class="italic">Org. Lett.</span>, 2003, <span class="bold">5</span>, 4227 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol035746r" title="DOI Link to resource 10.1021/ol035746r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCqs7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14572291%5Buid%5D" title="PubMed Link to resource 14572291">PubMed</a></span>; 
  (<i>&#102;</i>) <span id="cit10f">H. Zhou, Y. Liu, S. Yang, L. Zhou and M. Chang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2017, <span class="bold">56</span>, 2725 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201611181" title="DOI Link to resource 10.1002/anie.201611181">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXitVGltbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28140506%5Buid%5D" title="PubMed Link to resource 28140506">PubMed</a></span>; 
  (<i>&#103;</i>) <span id="cit10g">C. Yu, J. Wang and Y. Zhou, <span class="italic">Org. Chem. Front.</span>, 2018, <span class="bold">5</span>, 2805 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8QO00710A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8QO00710A">RSC</a></span>.</span></li>
      <li><span id="cit11">T. Yang, Q. Yin, G. Gu and X. Zhang, <span class="italic">Chem. Commun.</span>, 2018, <span class="bold">54</span>, 7247 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8CC03586E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8CC03586E">RSC</a>.</span></li>
      <li><span id="cit12">The real role of Ti(O<small><sup>i</sup></small>Pr)<small><sub>4</sub></small> is unclear at this stage. We also tested some other Lewis acids including AlCl<small><sub>3</sub></small>, InCl<small><sub>3</sub></small>, FeCl<small><sub>3</sub></small>, Zn(OTf)<small><sub>2</sub></small>, BF<small><sub>3</sub></small>·Et<small><sub>2</sub></small>O and Ti(OEt)<small><sub>4</sub></small>, and the results disclosed that only titanium Lewis acid
could efficiently accelerate the transformation (see the ESI<a title="Select to navigate to footnote" href="#fn1">†</a> for details).</span></li>
      <li><span id="cit13">Deuterium-label experiments with D<small><sub>2</sub></small> were conducted, which excluded i-PrOH as a potential hydrogen-transfer reagent and the possibility of involvement of hydrogenated enamine intermediates in this case (see the ESI<a title="Select to navigate to footnote" href="#fn1">†</a> for details).</span></li>
      <li><span id="cit14">
  (<i>&#97;</i>) <span id="cit14a">A. Joncour, A. Décor, S. Thoret, A. Chiaroni and O. Baudoin, <span class="italic">Angew. Chem., Int. Ed.</span>, 2006, <span class="bold">45</span>, 4149 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200600451" title="DOI Link to resource 10.1002/anie.200600451">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XmsFynsbg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16688690%5Buid%5D" title="PubMed Link to resource 16688690">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit14b">A. Joncour, A. Décor, J.-M. Liu, M.-E. Tran Huu Dau and O. Baudoin, <span class="italic">Chem.–Eur. J.</span>, 2007, <span class="bold">13</span>, 5450 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.200601764" title="DOI Link to resource 10.1002/chem.200601764">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cqtrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17352448%5Buid%5D" title="PubMed Link to resource 17352448">PubMed</a></span>.</span></li>
      <li><span id="cit15">S. Takagishi and M. Schlosser, <span class="italic">Synlett</span>, 1991, 119 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-1991-20650" title="DOI Link to resource 10.1055/s-1991-20650">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3MXitVKlurg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit16">For studies on amide rotamers, see 
  (<i>&#97;</i>) <span id="cit16a">W. E. Stewart and T. H. Slidell, <span class="italic">Chem. Rev.</span>, 1970, <span class="bold">70</span>, 517 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr60267a001" title="DOI Link to resource 10.1021/cr60267a001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE3cXltVyqsr4%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit16b">
            M. Oki, <span class="italic">The Chemistry of Rotational Iso-mers</span>, Springer-Verlag, New York,  1993 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/978-3-642-51024-3" title="DOI Link to resource 10.1007/978-3-642-51024-3">CrossRef</a></span>.</span></li>
      <li><span id="cit17">Rh-catalyzed asymmetric hydrogenation of α-dehydroamino acid derivatives has been recognized as a model reaction to test the effectiveness of new chiral phosphoramidite ligands. See 
  (<i>&#97;</i>) <span id="cit17a">W. Tang and X. Zhang, <span class="italic">Chem. Rev.</span>, 2003, <span class="bold">103</span>, 3029 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr020049i" title="DOI Link to resource 10.1021/cr020049i">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXktlaiurY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12914491%5Buid%5D" title="PubMed Link to resource 12914491">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit17b">Y. Fu, X. Guo, S. Zhu, A. Hu, J. Xie and Q. Zhou, <span class="italic">J. Org. Chem.</span>, 2004, <span class="bold">69</span>, 4648 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo049655z" title="DOI Link to resource 10.1021/jo049655z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXksF2hsL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15230585%5Buid%5D" title="PubMed Link to resource 15230585">PubMed</a></span>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=c8sc04482a" target="_blank" title="Select to resolve DOI: 10.1039/c8sc04482a">10.1039/c8sc04482a</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>